Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Qidong, China, 1992-2000 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total	Absolute survival %			Relative survival %			ASRS% at 5-years
Site	ICD-10	Total	1-year	3-year	5-year	1-year	3-year	5-year	all ages	0-74 years
C03-06	Oral cavity	35	44.6	32.2	32.2	46.0	35.5	36.2	40.3	43.8
C11	Nasopharynx	164	47.1	31.6	29.3	48.1	33.1	31.2	29.1	36.4
C15	Oesophagus	942	14.7	4.6	4.0	15.5	5.2	4.9	5.3	6.1
C16	Stomach	3254	28.0	16.6	15.4	29.2	18.3	18.0	17.9	20.1
C17	Small intestine	35	36.4	14.5	6.2	37.6	16.4	7.7	5.5	6.3
C18	Colon	315	49.5	34.6	32.9	51.5	38.0	38.9	36.7	42.1
C19-20	Rectum	1010	44.0	29.9	26.9	45.8	33.0	31.4	29.6	34.5
C22	Liver	7090	13.3	6.5	5.2	13.5	6.8	5.6	5.6	5.4
C23-24	Gall bladder	100	20.8	12.5	12.5	21.5	13.5	14.4	15.2	17.5
C25	Pancreas	661	11.9	6.8	6.5	12.4	7.6	8.0	8.6	6.7
C30-31	Nose/Sinuses	45	57.8	34.5	24.6	59.1	37.4	29.9	44.1	22.3
C32	Larynx	47	55.1	41.3	41.3	57.2	46.8	52.6	50.5	48.7
C33-34	Lung	3281	15.2	6.5	5.6	15.8	7.2	6.8	6.6	6.4
C37-38	Other thoracic organs	38	23.3	10.0	10.0	24.1	10.5	10.8	14.2	19.3
C40-41	Bone	149	27.5	14.3	13.0	28.2	15.6	14.8	13.7	15.2
C43	Melanoma skin	36	46.3	30.8	15.4	48.0	33.9	18.1	22.2	26.6
C44	Other skin	120	39.2	27.3	26.0	42.1	33.2	36.9	38.5	37.3
C47+C49	Connective tissue	32	50.8	27.8	27.8	51.8	30.0	30.9	26.8	36.2
C50	Breast	651	77.7	63.0	56.0	78.6	65.0	59.4	57.6	58.3
C53	Cervix	144	45.8	39.0	36.5	47.1	40.8	39.4	43.8	47.9
C54	Corpus uteri	69	76.9	62.6	54.9	78.5	66.0	59.3	53.8	62.2
C55	Uterus unspecified	41	46.2	33.6	33.6	47.7	35.3	35.7	28.6	34.9
C56	Ovary	101	51.3	34.7	32.7	52.1	36.2	36.1	41.0	35.1
C61	Prostate	55	37.7	25.1	25.1	40.2	29.2	32.5	31.1	36.3
C64	Kidney	72	36.7	31.0	24.5	37.4	32.7	26.8	28.9	26.7
C67	Urinary bladder	366	51.5	38.7	32.9	54.3	45.3	42.9	42.1	47.3
C70-72	Brain & nervous system	413	18.0	11.2	8.8	18.3	11.6	9.2	10.7	11.1
C73	Thyroid	48	75.6	72.8	72.8	77.0	75.6	78.2	77.8	76.8
C82-85+C96	Non-Hodgkin lymphoma	312	26.3	16.8	12.3	27.0	18.0	13.9	13.1	13.4
C90	Multiple myeloma	137	14.7	9.1	9.1	15.1	10.1	11.1	11.1	10.9
C91	Lymphoid leukaemia	81	21.0	6.8	4.5	21.3	7.1	4.8	4.1	5.4
C92-94	Myeloid leukaemia	216	19.1	7.2	5.3	19.3	7.5	5.7	6.6	6.0
C95	Leukaemia unspecified	107	13.6	7.6	6.5	13.8	7.8	6.9	5.8	7.1

Graphs:

1-, 3- and 5-year absolute survival (%)

1-, 3- and 5-year relative survival (%)

ASRS (%) all ages

ASRS (%) 0-74 years

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1991 and 1992-2000 (Qidong, China)
- Table6b:	Number of cases by cancer site and calendar period (Qidong, China, 1977-2000)
- Table7:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Qidong, China, 1977-2000 cases followed-up until 2000)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)